CORT

#3683
Corcept Therapeutics Incorporated - Common Stock
0.6 9 USD
-98.98%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
0.69
0.69
Faixa anual
0.69
89.00
Mudança diária
-98.98%
Mudança mensal
-98.52%
Mudança em 6 meses
-99.11%
Mudança anual
-99.05%
Fechamento anterior
68.3 8
Open
0.6 9
Mínimo
0.6 9
High
0.6 9
Volume
220
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 74.6 M
  • Employee 730
  • Founded 1998
  • CEO N/A
  • Website www.corcept.com
  • Headquarter Delaware, United States
  • FIGI BBG000BKJG33
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
42.44
Índice preço/fluxo de caixa
5.48

Corcept Therapeutics Incorporated - Common Stock

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Notícias